Nuclear Medicine is a branch of medicine in which radioactive substances (gamma, beta, alpha emitters) are used and administered individually or together with different drugs (radiopharmaceuticals), which are directed to specific organs of the body providing diagnostic information, follow-up, and evaluation of response to treatment of different diseases.
We perform diagnostic studies: scintigraphy and PET /CT, and Treatments: Metabolic Therapies
The pathologies diagnosed and treated in the Nuclear Medicine service are diverse, such as cancer, coronary disease, heart disease, gastrointestinal, endocrine, neurological disorders, kidney diseases such as hydronephrosis, infections, osteoarticular disease and other medical conditions such as dementia and convulsive syndrome.
The techniques of these procedures are characterized by being non-invasive. The patient is exposed to low levels of irradiation. They are procedures that provide complementary information to other tests such as radiological studies, ultrasound, and catheterization. They can be used in both adult and pediatric patients. Most of them require preparation according to the type of study.
All patients undergo a clinical history to know the justification for the study and provide the pertinent indications once the radiopharmaceutical is carried out.
As part of patient safety regulations, all women of reproductive age (who have menstrual cycles) must present a pregnancy test no more than 5 days before the procedure, to avoid inadvertent radiation exposure to a pregnant woman.
Nuclear Medicine diagnostic studies differ from Radiological studies because the equipment is the one that emits the radiation, and it reaches the patient. In the case of Nuclear Medicine, the patient is administered the radioactive material in safe doses, so that he emits the radiation and the equipment can detect it and thus generate the images.
Radioactive materials used for diagnostic studies have short lives and the activity decreases over time. Most of them are eliminated through urine and fecal matter, etc. In each particular case and test, the procedure will be explained to the patient and the recommendations to follow once the radiopharmaceutical has been administered will be given.
Lymphatic System Studies
Genitourinary System Studies
Musculoskeletal System Review
Positron emission tomography (pet-CT)
Our Nuclear Medicine service started its activities with a dedicated team to perform planar and tomographic scintigraphy (SPECT).
We were the first in Colombia in having a new imaging perspective, called Hybrid Imaging, which consists of performing Nuclear Medicine images and taking a CT scan at the same time as the study.
Nuclear Medicine Molecular Imaging technology is implemented, the first PET/CT (Positron Emission Tomography) in the southwest of the country.
We have experienced hospital physicians dedicated to evaluating the patient before the performance of their procedures to ensure proper preparation and condition of the patient.
The Nuclear Medicine section has 30 years of experience in Cali. The service is characterized as being the reference center in the country with international recognition.
We have been pioneers in the country in diagnostic studies such as the evaluation of renal transplantation, and the evaluation of Parkinson's disease.
We were pioneers in the implementation of the use of B-emitting drugs in the palliative management of bone pain, synoviolysis, and intratumoral administration in cystic tumors of the central nervous system.
We have the first PET/CT in the southwest.
Likewise, we have performed 9500 PET/CT studies.
We also provide 24/7 service in case of emergencies and hospitalized patients.
Good experience with the entire human, medical, and assistance team.
The service is characterized as being the reference center in the country with international recognition.
Do you live outside of Colombia?, Are you interested in receiving information about Molecular Nuclear Medicine at La Fundación Valle del Lili? contact us at the following link: